[1. T. McInnis, L. Strand and C. E. Webb, Integrating Comprehensive Medication Management to Optimize Patient Outcomes, Resour. Guid. (2012) A-26.]Search in Google Scholar
[2. Institute of Medicine, Informing the Future: Critical Issues in Health: Fourth Edition, The National Academies Press, Washington DC 2007; https://doi.org/10.17226/1201410.17226/12014]Search in Google Scholar
[3. OECD/EU, Health at a Glance: Europe 2018: State of Health in the EU Cycle, OECD Publishing, Paris/EU, Brussels 2018; https://doi.org/10.1787/health_glance_eur-2018-en10.1787/health_glance_eur-2018-en]Search in Google Scholar
[4. World Health Organization, Noncommunicable diseases key facts, June 2018; https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases; access date April 29, 2019.]Search in Google Scholar
[5. J. H. Watanabe, T. McInnis and J. D. Hirsch, Cost of Prescription Drug–Related Morbidity and Mortality, Ann. Pharmacother.52 (2018) 829-837; https://doi.org/10.1177/106002801876515910.1177/1060028018765159]Search in Google Scholar
[6. F. R. Ernst and A. J. Grizzle, Drug-related morbidity and mortality: Updating the cost-of-illness model, J. Am. Pharm. Assoc.41 (2001) 192-199; https://doi.org/10.1016/S1086-5802(16)31229-310.1016/S1086-5802(16)31229-3]Search in Google Scholar
[7. J. A. Johnson and J. L. Bootman, Drug-related morbidity and mortality and the economic impact of pharmaceutical care, Am. J. Health-Syst. Pharm.54 (1997) 554-558; https://doi.org/10.1093/ajhp/54.5.55410.1093/ajhp/54.5.5549066865]Search in Google Scholar
[8. K. Wiedenmayer, R. S. Summers; C. A. Mackie, A. G. S. Gous, M. Everard and D. Tromp, Developing pharmacy practice – A focus on patient care, World Health Organization and International Pharmaceutical Federation, Geneva and The Hague 2006; https://apps.who.int/iris/handle/10665/69399; access date April 29, 2019.]Search in Google Scholar
[9. R. J. Cipolle, L. M. Strand and P. C. Morley, Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management, 3rd ed., The McGraw-Hill Companies, New York 2012.]Search in Google Scholar
[10. Public Law, 117 STAT. 2066, PUBLIC LAW 108–173—DEC. 8, 2003, The Medicare Prescription Drug, Improvement, and Modernization Act of 2003, December 2003; https://www.govinfo.gov/app/details/PLAW-108publ173; access date April 29, 2019.]Search in Google Scholar
[11. I. Torjesen, More than 400 pharmacists will be recruited to GP surgeries by next year, BMJ351 (2015) Article ID h6167 (2 pages); https://doi.org/10.1136/bmj.h616710.1136/bmj.h616726572158]Search in Google Scholar
[12. Australian Medical Association, Analysis of non-dispensing pharmacists in general practice clinics, Deloitte Access Economics, Sydney 2015; https://www2.deloitte.com/au/en/pages/economics/articles/analysis-non-dispensing-pharmacists-general-practice-clinics.html; access date April 29, 2019.]Search in Google Scholar
[13. L. Dolovich, K. Pottie, J. Kaczorowski, B. Farrell, Z. Austin, C. Rodriguez, K. Gaebel and C. Sellors, Integrating family medicine and pharmacy to advance primary care therapeutics, Clin. Pharmacol. Ther.83 (2008) 913-917; https://doi.org/10.1038/clpt.2008.2910.1038/clpt.2008.2918388882]Search in Google Scholar
[14. S. de A. M. Mendonça, A. C. Melo, G. C. C. Pereira, D. M. de S. S. dos Santos, E. B. Grossi, M. do C. V. B. Sousa, D. R. de Oliveira and A. C. Soares, Clinical outcomes of medication therapy management services in primary health care, Braz. J. Pharm. Sci.52 (2016) 365-373; http://dx.doi.org/10.1590/s1984-8250201600030000210.1590/s1984-82502016000300002]Search in Google Scholar
[15. A. O. M. Mourão, W. R. Ferreira, M. A. P. Martins, A. M. M. Reis, M. R. G. Carrillo, A. G. Guimarães and L. S. Ev, Pharmaceutical care program for type 2 diabetes patients in Brazil: A randomised controlled trial, Int. J. Clin. Pharm.35 (2013) 79-86; https://doi.org/10.1007/s11096-012-9710-710.1007/s11096-012-9710-723161124]Search in Google Scholar
[16. G. C. B. de Oliveira, M. R. Alves and D. R. de Oliveira, Action Research as a Tool for Transformation of the Pharmacist’s Praxis in Primary Care, Int. J. Pharm. Pharm. Sci.9 (2017) 180-185; https://doi.org/10.22159/ijpps.2017v9i3.1648610.22159/ijpps.2017v9i3.16486]Search in Google Scholar
[17. L. M. Strand, R. J. Cipolle, P. C. Morley and M. J. Frakes, The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience, Curr. Pharm. Des.10 (2004) 3987-4001; https://doi.org/10.2174/138161204338257610.2174/138161204338257615579084]Search in Google Scholar
[18. D. R. de Oliveira, A. R. Brummel and D. B. Miller, Medication therapy management: 10 years of experience in a large integrated health care system, J. Manag. Care Spec Pharm.16 (2010) 185-195; https://doi.org/10.18553/jmcp.2010.16.3.18510.18553/jmcp.2010.16.3.18520331323]Search in Google Scholar
[19. D. Rao, A. Gilbert, L. M. Strand and R. J. Cipolle, Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia, Pharm. World Sci.29 (2007) 647-654; https://doi.org/10.1007/s11096-007-9123-110.1007/s11096-007-9123-117450422]Search in Google Scholar
[20. L. G. Planas, K. M. Crosby, K. D. Mitchell and K. C. Farmer, Evaluation of a hypertension medication therapy management program in patients with diabetes, J. Am. Pharm. Assoc.49 (2009) 164-170; https://doi.org/10.1331/JAPhA.2009.0816410.1331/JAPhA.2009.0816419289342]Search in Google Scholar
[21. A. Brummel and A. M. Carlson, Comprehensive Medication Management and Medication Adherence for Chronic Conditions, J. Manag. Care Spec. Pharm.22 (2016) 56-62; https://doi.org/10.18553/jmcp.2016.22.1.5610.18553/jmcp.2016.22.1.5627015052]Search in Google Scholar
[22. C. W. Cranor, B. A. Bunting and D. B. Christensen, The Asheville Project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program, J. Am. Pharm. Assoc.43 (2003) 173-184; https://doi.org/10.1331/10865800332148071310.1331/10865800332148071312688435]Search in Google Scholar
[23. B. J. Isetts, S. W. Schondelmeyer, M. B. Artz, L. a Lenarz, A. H. Heaton, W. B. Wadd, L. M. Brown and R. J. Cipolle, Clinical and economic outcomes of medication therapy management services: the Minnesota experience, J. Am. Pharm. Assoc.48 (2008) 203-214; https://doi.org/10.1331/JAPhA.2008.0710810.1331/JAPhA.2008.0710818359733]Search in Google Scholar
[24. K. B. Detoni, I. V Oliveira, M. M. G. Nascimento, T. R. Caux, M. R. Alvares and D. R. de Oliveira, Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease, Int. J. Clin. Pharm.39 (2016) 95-103; https://doi.org/10.1007/s11096-016-0402-6.10.1007/s11096-016-0402-627915426]Search in Google Scholar
[25. P. R. Obreli-Neto, S. Marusic, C. M. Guidoni, A. de O. Baldoni, R. D. Renovato, D. Pilger, R. K. N. Cuman and L. R. L. Pereira, Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial, J. Manag. Care Spec. Pharm.21 (2015) 66-75; https://doi.org/10.18553/jmcp.2015.21.1.6610.18553/jmcp.2015.21.1.6625562774]Search in Google Scholar
[26. H. Schultz, S. M. Westberg, D. R. de Oliveira and A. Brummel, Patient-perceived value of Medication Therapy Management (MTM) services: a series of focus groups, Innov. Pharm.3 (2012) Article ID 96 (8 pages); https://doi.org/10.24926/iip.v3i4.27810.24926/iip.v3i4.278]Search in Google Scholar
[27. D. G. Garrett and L. A. Martin, The Asheville Project: Participants’ perceptions of factors contributing to the success of a patient self-management diabetes program, J. Am. Pharm. Assoc.43 (2003) 185-190; https://doi.org/10.1331/10865800332148072210.1331/10865800332148072212688436]Search in Google Scholar
[28. O. A. Abdela, A. S. Bhagavathula, H. Getachew and Y. Kelifa, Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia, J. Pharm. BioAllied Sci.8 (2016) 289-295; https://doi.org/10.4103/0975-7406.19933510.4103/0975-7406.199335531482728216952]Search in Google Scholar
[29. Y. L. Niriayo, K. Kumela, T. D. Kassa and M. T. Angamo, Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia, PLoS One13 (2018) Article ID e0206120 (14 pages); https://doi.org/10.1371/journal.pone.020612010.1371/journal.pone.0206120619897330352096]Search in Google Scholar
[30. S. I. Al-Azzam, K. H. Alzoubi, S. Aburuz and Q. Alefan, Drug-related problems in a sample of out-patients with chronic diseases: A cross-sectional study from Jordan, Ther. Clin. Risk Manag.12 (2016) 233-239; https://doi.org/10.2147/TCRM.S9816510.2147/TCRM.S98165476243826937195]Search in Google Scholar
[31. O. Urbina, O. Ferrández, S. Luque, S. Grau, S. Mojal, R. Pellicer, M. Riu, E. Salas and J. Comin-Colet, Patient risk factors for developing a drug-related problem in a cardiology ward, Ther. Clin. Risk Manag.11 (2014) 9-15; https://doi.org/10.2147/TCRM.S7174910.2147/TCRM.S71749427511125565852]Search in Google Scholar
[32. K. Lewin, Field Theory In Social Science; Selected Theoretical Papers (D. Cartwright, Ed.). Harper & Brothers Publisher New York, New York 1976.]Search in Google Scholar
[33. C. Blanchard, M. Livet, C. Ward, L. Sorge, T. D. Sorensen and M. R. McClurg, The active implementation frameworks: A roadmap for advancing implementation of comprehensive medication management in primary care, Res. Social Adm. Pharm.13 (2017) 922-929; https://doi.org/10.1016/j.sapharm.2017.05.00610.1016/j.sapharm.2017.05.00628549800]Search in Google Scholar
[34. M. Livet, C. Blanchard, T. D. Sorensen and M. R. McClurg, An implementation system for medication optimization: Operationalizing comprehensive medication management delivery in primary care, J. Am. Coll. Clin. Pharm.1 (2018) 14-20; https://doi.org/10.1002/jac5.103710.1002/jac5.1037]Search in Google Scholar
[35. Health Centre Zagreb – Centre and MCS Grupa d.o.o., Health.net PRO (Zdravlje.net PRO), https://dzzcentar.hr/projekti/zdravlje-net-pro/; access date April 29, 2019.]Search in Google Scholar
[36. A. Bowling, Research Methods in Health: investigating health and health services, 3rd ed., The McGraw-Hill Companies, New York 2009, pp. 222-223.]Search in Google Scholar
[37. D. L. Pestka, L. A. Sorge, M. R. McClurg and T. D. Sorensen, The Philosophy of Practice for Comprehensive Medication Management: Evaluating Its Meaning and Application by Practitioners, Pharmacotherapy38 (2018) 69-79; https://doi.org/10.1002/phar.206210.1002/phar.206229155443]Search in Google Scholar
[38. The Agency for Medicinal Products and Medical Devices, Croatia, Medicinal Products Database, 2019; http://www.halmed.hr/en/Lijekovi/Baza-lijekova/; access date April 20, 2019.]Search in Google Scholar
[39. J. T. DiPiro, R. L. Talbert, G. C. Yee, G. R. Matzke, B. G. Wells, L. M. Posey, Pharmacotherapy A Pathophysiologic Approach, 10th ed., McGraw-Hill Education, New York 2017.]Search in Google Scholar
[40. D. L. Krinsky, S. P. Ferreri, B. Hemstreet, A. L. Hume, G. D. Newton, C. J. Rollins, K. J. Tietze, Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th ed., American Pharmacists Association, Washington, DC 2018; https://doi.org/10.21019/978158212265610.21019/9781582122656]Search in Google Scholar
[41. UpToDate, Post, TW (Ed), UpToDate, Waltham, MA 2019; https://www.uptodate.com/contents/search; access date April 20, 2019.]Search in Google Scholar
[42. P. A. do Amaral, S. de A. M. Mendonça, D. R. de Oliveira, L. J. Peloso, R. D. S. Pedroso and M. Â. Ribeiro, Impact of a medication therapy management service offered to patients in treatment of breast cancer, Braz. J. Pharm. Sci.54 (2018) Article ID e00221 (12 pages); http://dx.doi.org/10.1590/s2175-9790201800020022110.1590/s2175-97902018000200221]Search in Google Scholar
[43. D. R. de Oliveira, Pharmaceutical care uncovered: an ethnographic study of pharmaceutical care practice, University of Minnesota, Minneapolis 2003.]Search in Google Scholar
[44. S. de A. M. Mendonça, E. L. de Freitas and D. R. de Oliveira, Competencies for the provision of comprehensive medication management services in an experiential learning project, PLoS One12 (2017) e0185415 (14 pages); https://doi.org/10.1371/journal.pone.018541510.1371/journal.pone.0185415561457028950021]Search in Google Scholar
[45. E. L. de Freitas and D. R. de Oliveira, Critical thinking in the context of clinical practice: The need to reinvent pharmacy education, Rev. Port. Educ.28 (2015) 231-250; https://doi.org/10.21814/rpe.775310.21814/rpe.7753]Search in Google Scholar
[46. M. Rosenthal, Z. Austin and R. T. Tsuyuki, Are pharmacists the ultimate barrier to pharmacy practice change?, Can. Pharm. J.143 (2010) 37-42; https://doi.org/10.3821/1913-701X-143.1.3710.3821/1913-701X-143.1.37]Search in Google Scholar
[47. M. Â. Ribeiro, S. A. M. Araújo, M. Mendonça, A. F. R. Filardi, A. C. Y. dos Anjos and D. R. de Oliveira, Implementation and systematization of a comprehensive medication management (CMM) service delivered to women with breast cancer, Asian J. Pharm. Clin. Res.11 (2018) 228-235; https://doi.org/10.22159/ajpcr.2018.v11i1.2153710.22159/ajpcr.2018.v11i1.21537]Search in Google Scholar
[48. A. B. Blondal, S. K. Sporrong and A. B. Almarsdottir, Introducing Pharmaceutical Care to Primary Care in Iceland - An Action Research Study, Pharmacy (Basel)5 (2017) 23 (11 pages); https://doi.org/10.3390/pharmacy502002310.3390/pharmacy5020023559714828970435]Search in Google Scholar
[49. L. S. Nørgaard and E. W. Sørensen, Action research methodology in clinical pharmacy: how to involve and change, Int. J. Clin. Pharm.38 (2016) 739-745; https://doi.org/10.1007/s11096-016-0310-910.1007/s11096-016-0310-927156114]Search in Google Scholar
[50. T. D. Sorensen, D. L. Pestka, A. R. Brummel, D. J. Rehrauer and M. J. Ekstrand, Seeing the forest through the trees: improving adherence alone will not optimize medication use, J. Manag. Care Spec. Pharm. 22 (2016) 598-604; https://doi.org/10.18553/jmcp.2016.22.5.59810.18553/jmcp.2016.22.5.59827123920]Search in Google Scholar